(Updated - June 2, 2026 7:37 AM EDT)

Wedbush analyst David Nierengarten upgraded Abivax (NASDAQ: ABVX) from Underperform to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE